Autoimmune astrocytopathy double negative for AQP4-IgG and GFAP-IgG: Retrospective research of clinical practice, biomarkers, and pathology.

Pei-Hao LinHai-Yan YaoLi HuangCong-Cong FuXiao-Li YaoChun LianShi-Feng ZhangWen-Dong LaiGuan-Yan LinSha LiaoJie YangZhi-Feng MaoDing LiuBao-Yi LongJia-Jia YueCong GaoYou-Ming Long

Published in: CNS neuroscience & therapeutics (2024)

There are unidentified astrocyte antibodies. The manifestations of double-negativity are heterogeneous; nevertheless, the pathology and biomarkers remain consistent with astrocytopathy. Immunotherapy is effective.

Keyphrases

clinical practice
multiple sclerosis
cross sectional
drug induced